IMTX vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 05, 2026

IMTX

36.7
AI Score
VS
SYRE Wins

SYRE

45.0
AI Score

Investment Advisor Scores

IMTX

37score
Recommendation
AVOID NEW MONEY

SYRE

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric IMTX SYRE Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 93.0% 0.0% IMTX
Earnings Growth 0.0% -99.7% IMTX
Tradestie Score 36.7/100 45.0/100 SYRE
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD SYRE

Relative Price Performance (Last 90 Days)

IMTX 1M: -7.9% · 3M: -31.7% SYRE 1M: +31.5% · 3M: -0.2%

Current Technical Phase

IMTX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -10.9%), weak momentum, RSI 37

RSI (14): 36.8 · Price: $6.45

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 59

RSI (14): 58.9 · Price: $103.40

Fundamentals Snapshot

Metric IMTX SYRE
Market Cap — —
Forward P/E -3.4 -28.9
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.9% 0.0%
Gross Margin -4.2% —
Operating Margin -7.3% 0.0%
EPS -1.95 -2.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.